Nicotinamide is also a substrate of nicotinamide phosphoribosyltransferase (NAMPT) that converts it to nicotinamide adenine dinucleotide (NAD+), whose 15N-labeled fraction accounted for ~24% of the total pool in the tumor tissue (Fig. 3S). This evidence concerns the gene NAMPT and neoplasm.